Literature DB >> 9605514

Progesterone can participate in down-regulation of the luteinizing hormone receptor gene expression and function in cultured murine Leydig cells.

T El-Hefnawy1, I Huhtaniemi.   

Abstract

The intratesticular concentration of progesterone (P) rises up to the micromolar range during high-dose luteinizing hormone (LH)/hCG stimulation. The aim of this study was to examine whether P is involved in the concomitant down-regulation of the LH receptor (R) function. The effects were tested in a mouse Leydig tumor cell line (mLTC-1) and in Percoll-purified adult mouse Leydig cells. Pre-incubation of the mLTC-1 cells for 48 h with P (1-10 micromol/l) decreased in dose-dependent fashion their specific binding of [125I]iodo-hCG as well as the hCG-induced cAMP production (down to 65 and 40% respectively, of controls, P < 0.01). Similar effect of P on hCG-induced cAMP production was observed in adult mouse Leydig cells following a 24 h incubation in the presence of P (0.3-10 micromol/l). In addition, P treatment significantly inhibited the expression of a transiently transfected murine LHR promoter (715 or 950 bp of the 5' untranslated region)-luciferase fusion constructs in mLTC-1 cells (down to 50% of control, P < 0.01). In accordance, a 6-12 h culture in the presence of 5-10 micromol/l of P showed significant down-regulatory effects on the steady state levels of LHR-mRNA in mLTC-1 cells. These inhibitory effects of P on the LHR expression and function were mimicked by similar concentrations of cortisol, but not by testosterone or estradiol. Blocking the steroid synthesis of mLTC-1 cells with 86 micromol/l of aminoglutethimide (AMG) partially reversed the down-regulating effect of hCG on the LHR-mRNA. Moreover, a 24 h culture in the presence of AMG showed an up-regulating effect on expression of the LHR promoter-luciferase constructs, and including hCG (50 microg/l) in the culture medium enhanced this effect. Hence, in the absence of steroidogenesis, hCG up-regulates the LHR promoter expression. In conclusion, we present here a novel short-loop regulatory mechanism in murine Leydig cells where P exerts a negative effect on LHR expression and function. Since Leydig cell P production is dramatically increased during high-dose stimulation with LH/hCG, due to blockade of C21 steroid side chain cleavage, the present findings offer a function for this steroid in the LHR down-regulation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9605514     DOI: 10.1016/s0303-7207(98)00002-1

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  5 in total

Review 1.  The endocrine pharmacology of testosterone therapy in men.

Authors:  Michael Oettel
Journal:  Naturwissenschaften       Date:  2004-01-28

2.  The role of combining medroxyprogesterone 17-acetate with human menopausal gonadotropin in mouse ovarian follicular development.

Authors:  Xiaowei Wen; Jun Xie; Lixia Zhou; Yong Fan; Baofeng Yu; Qiuju Chen; Yonglun Fu; Zheng Yan; Haiyan Guo; Qifeng Lyu; Yanping Kuang; Weiran Chai
Journal:  Sci Rep       Date:  2018-03-13       Impact factor: 4.379

3.  The Effects of Separate and Combined Treatment of Male Rats with Type 2 Diabetes with Metformin and Orthosteric and Allosteric Agonists of Luteinizing Hormone Receptor on Steroidogenesis and Spermatogenesis.

Authors:  Andrey A Bakhtyukov; Kira V Derkach; Viktor N Sorokoumov; Anna M Stepochkina; Irina V Romanova; Irina Yu Morina; Irina O Zakharova; Liubov V Bayunova; Alexander O Shpakov
Journal:  Int J Mol Sci       Date:  2021-12-24       Impact factor: 5.923

4.  Testicular Macrophages Produce Progesterone De Novo Promoted by cAMP and Inhibited by M1 Polarization Inducers.

Authors:  Sawako Yamauchi; Kousuke Yamamoto; Kazushige Ogawa
Journal:  Biomedicines       Date:  2022-02-18

Review 5.  Progesterone: A Steroid with Wide Range of Effects in Physiology as Well as Human Medicine.

Authors:  Lucie Kolatorova; Jana Vitku; Josef Suchopar; Martin Hill; Antonin Parizek
Journal:  Int J Mol Sci       Date:  2022-07-20       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.